ArticleCureus2025
Two Cases of Subarachnoid Hemorrhage Associated With COVID-19 Infection Yielding Favorable Functional Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subarachnoid hemorrhage (SAH) is a life-threatening cerebrovascular disorder characterized by high mortality and unfavorable long-term outcomes. During the COVID-19 pandemic, SARS-CoV-2 infection has been associated with systemic inflammation and coagulopathy, which may result in cerebrovascular complications such as intracranial hemorrhage (ICH). However, the characteristics and outcomes of COVID-19-associated SAH remain unclear, and favorable outcomes are rarely reported. We encountered two male patients with COVID-19-associated SAH, one with a non-aneurysmal SAH and another with a ruptured vertebral artery dissecting aneurysm, both of whom achieved favorable recovery following appropriate management. These cases suggest that early diagnosis, prevention of rebleeding, and timely standard treatment can lead to good outcomes even in COVID-19-associated SAH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.